Trials / Completed
CompletedNCT00519506
A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary Emboli
A Phase II Study to Evaluate the Efficacy of Anti-Fibrin Humanized Monoclonal Antibody(DI-DD3B6/22-80B3) Fab' Fragment (ThromboView®) Conjugated With Technetium-99m in the Detection of Pulmonary Emboli
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Agen Biomedical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to determine the diagnostic accuracy of 99mTc ThromboView® SPECT imaging for the detection of acute pulmonary embolism (PE) in patients for whom there is a moderate to high clinical suspicion for PE.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ThromboView | Radiopharmaceutical, single dose, of the diagnosis of venous thromboembolism |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2008-06-01
- Completion
- 2008-10-01
- First posted
- 2007-08-22
- Last updated
- 2009-04-14
Locations
6 sites across 2 countries: United States, Canada
Source: ClinicalTrials.gov record NCT00519506. Inclusion in this directory is not an endorsement.